Objectives: Clostridioides difficile infection (CDI) is a considerable healthcare and economic burden worldwide. Faecal microbial transplant remains the most effective treatment for CDI, but is not at the present time the recommended standard of care. We hereby investigate which factors derived from a healthy gut microbiome might constitute the colonisation resistance barrier (CRB) in the gut, inhibiting CDI. Method: CRB drivers pH, short chain fatty acid (SCFA), and oxidation-reduction potential (ORP) were investigated in vitro using C. difficile NAP1/BI/027. Readouts for inhibitory mechanisms included germination, growth, toxin production and virulence gene expression. pH ranges (3 – 7.6), SCFA concentrations (25 – 200mM) and ORP (...
Disturbance in gut microbiota is crucial for the development of Clostridioides difficile infection (...
Clostridium difficile is known for causing the nosocomial diarrhoeal disease, C. difficile infection...
The bacterium Clostridium difficile is the leading cause of healthcare associated diarrhoea in the d...
Problem: Clostridioides difficile infections (CDI) have emerged as the leading cause of hospital-acq...
Background and aims Clostridium difficile infection (CDI) remains a healthcare burden and recurrent...
Background & Aims Fecal microbiota transplantation (FMT) is effective for treating recurrent Clostri...
The leading risk factor for Clostridioides (Clostridium) difficile infection (CDI) is broad-spectrum...
Clostridioides difficile is the leading cause of antibiotic associated diarrhoea, causing significan...
Clostridioides difficile is a Gram-positive, anaerobic, spore-forming bacillus and is a major cause ...
Clostridium difficile infection (CDI) currently affects around 20,000 people each year, in healthca...
Clostridioides (Clostridium) difficile infections (CDI) have become the leading cause of nosocomial ...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
peer reviewedClostridioides difficile is an anaerobic Gram-positive and spore-forming bacterium. The...
The gastrointestinal microbiome plays an important role in limiting susceptibility to infection with...
Clostridium difficile is an anaerobic, Gram-positive, endospore forming bacillus and is the leading ...
Disturbance in gut microbiota is crucial for the development of Clostridioides difficile infection (...
Clostridium difficile is known for causing the nosocomial diarrhoeal disease, C. difficile infection...
The bacterium Clostridium difficile is the leading cause of healthcare associated diarrhoea in the d...
Problem: Clostridioides difficile infections (CDI) have emerged as the leading cause of hospital-acq...
Background and aims Clostridium difficile infection (CDI) remains a healthcare burden and recurrent...
Background & Aims Fecal microbiota transplantation (FMT) is effective for treating recurrent Clostri...
The leading risk factor for Clostridioides (Clostridium) difficile infection (CDI) is broad-spectrum...
Clostridioides difficile is the leading cause of antibiotic associated diarrhoea, causing significan...
Clostridioides difficile is a Gram-positive, anaerobic, spore-forming bacillus and is a major cause ...
Clostridium difficile infection (CDI) currently affects around 20,000 people each year, in healthca...
Clostridioides (Clostridium) difficile infections (CDI) have become the leading cause of nosocomial ...
Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life th...
peer reviewedClostridioides difficile is an anaerobic Gram-positive and spore-forming bacterium. The...
The gastrointestinal microbiome plays an important role in limiting susceptibility to infection with...
Clostridium difficile is an anaerobic, Gram-positive, endospore forming bacillus and is the leading ...
Disturbance in gut microbiota is crucial for the development of Clostridioides difficile infection (...
Clostridium difficile is known for causing the nosocomial diarrhoeal disease, C. difficile infection...
The bacterium Clostridium difficile is the leading cause of healthcare associated diarrhoea in the d...